menu
    • menu

    Company profile for PhotonPharma

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    PhotonPharma is at the forefront of immuno-oncology, pioneering a revolutionary technology designed to activate a patient's immune system for targeted destruction of their cancer cells. The company boasts a patent-protected process that precisely inactivates the DNA/RNA of a patient's tumor cells, preserving all unique tumor-specific antigen targets (neoantigens) while keeping the cells alive. This innovative process is simple...
    PhotonPharma is at the forefront of immuno-oncology, pioneering a revolutionary technology designed to activate a patient's immune system for targeted destruction of their cancer cells. The company boasts a patent-protected process that precisely inactivates the DNA/RNA of a patient's tumor cells, preserving all unique tumor-specific antigen targets (neoantigens) while keeping the cells alive. This innovative process is simple, rapid, and cost-effective, allowing a patient's inactivated tumor cells to be extracted, treated, and administered back on the same day.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PhotonPharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Fort Collins, CO 80521
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://photonpharmaceuticals.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/photonpharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Photonpharma Appoints Vaccine Innovation Leader To Board
    Photonpharma Appoints Vaccine Innovation Leader To Board

    22 Jan 2026

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/photonpharma-inc-appoints-vaccine-innovation-leader-william-warren-phd-to-board-of-directors-302667466.html

    PR NEWSWIRE BIO
    22 Jan 2026
    Share Share
    PhotonPharma CEO to Present Autologous Cancer Therapy Platform
    PhotonPharma CEO to Present Autologous Cancer Therapy Platform

    01 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/photonpharma-inc-ceo-to-present-novel-autologous-treatment-platform-at-premier-cancer-immunotherapy-conference-302571857.html

    PR NEWSWIRE
    01 Oct 2025
    Share Share
    PhotonPharma Gets U.S. Patent for Novel Cancer Immunotherapy
    PhotonPharma Gets U.S. Patent for Novel Cancer Immunotherapy

    09 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/photonpharma-inc-receives-us-patent-for-innovative-cancer-immunotherapy-302549952.html

    PR NEWSWIRE
    09 Sep 2025
    Share Share
    PhotonPharma Inc. Appoints Derek Brown as New CEO
    PhotonPharma Inc. Appoints Derek Brown as New CEO

    24 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/photonpharma-inc-appoints-derek-brown-as-new-ceo-302286513.html

    PR NEWSWIRE
    24 Oct 2024
    Share Share
    PhotonPharma Secures $2.5M Seed Funding For Ovarian Cancer Trial
    PhotonPharma Secures $2.5M Seed Funding For Ovarian Cancer Trial

    21 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/photonpharma-secures-2-5-million-in-seed-funding-to-advance-clinical-trial-for-ovarian-cancer-treatment-302227761.html

    PR NEWSWIRE
    21 Aug 2024
    Share Share
    PhotonPharma Receives FDA Clearance for a Study for Ovarian Cancer Treatment
    PhotonPharma Receives FDA Clearance for a Study for Ovarian Cancer Treatment

    05 Mar 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/photonpharma-inc--receives-fda-clearance-for-a-first-in-human-clinical-study-for-stage-iiiiv-ovarian-cancer-treatment-with-the-investigational-autologous-vaccine-therapy-innocell-302079350.html

    PR NEWSWIRE
    05 Mar 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search